Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical-stage specialty pharmaceutical company focused on novel treatments for rare and orphan diseases, today announced that it has initiated the testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback